Pharsight introduces new software platform for model-based drug development

Pharsight, a provider of software and scientific services to improve productivity and decision-making in clinical drug development, has launched Phoenix WinNonlin, the next generation of the company's industry-standard software tool for pharmacokinetic and pharmacodynamic modeling and noncompartmental analysis.

Phoenix WinNonlin 6.0 is the cornerstone of Phoenix, Pharsight's new desktop software platform that is designed to advance model-based drug development by providing an integrated environment for data analysis, modeling and simulation, the company said.

According to Pharsight, the major features of Phoenix WinNonlin 6.0 include a new graphical user interface that makes creation and re-use of PK/PD analysis workflows seamless and intuitive, powerful native graphics and improved data management tools. Phoenix WinNonlin will be backward-compatible with WinNonlin versions 4 and 5. Phoenix WinNonlin will continue to operate with Pharsight's enterprise pharmacokinetic and pharmacodynamic (PK/PD) data management system, Pharsight Knowledgebase Server (PKS), and can also be used independently of PKS.

In addition to the release of Phoenix WinNonlin 6.0, newly released Phoenix Connect software integrates applications built on the Phoenix platform with commonly used third-party analysis and modeling tools such as S-PLUS, NONMEM and SAS, and enables data import/export with emerging industry standards such as CDISC, the company said.

Concurrent with the release of Phoenix WinNonlin 6.0, Pharsight has also released version 4.0 of Pharsight Knowledgebase Server (PKS). PKS is an enterprise data management system for secure storage and tracking of PK/PD data and analyses that is tightly integrated with Phoenix WinNonlin and earlier WinNonlin versions, as well as Pharsight's complementary software tools for PK analysis automation and reporting. The major features of PKS 4.0 include new web user interface enhancements for navigation of study and scenario data, improved data transfer utilities, and configurable data mining capabilities, the company added.

Daniel Weiner, senior vice president and chief technology officer of Pharsight, said: "Phoenix WinNonlin version 6.0 merges the trusted algorithms from WinNonlin with new powerful data management tools and high-quality graphics to support comprehensive PK/PD analysis.

"The Phoenix platform has been developed to provide a collaborative environment for drug development scientists and to shorten the learning curve to more complex and impactful modeling, which ultimately supports more confident and efficient clinical development decisions."

http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall 
not be liable for errors or delays in the content, or for any actions 
taken in reliance thereon

Related terms: clinical, environment, graphics, knowledge management, president, productivity, science, software, standards, utilities